WO2011152652A3 - 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제 - Google Patents

1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제 Download PDF

Info

Publication number
WO2011152652A3
WO2011152652A3 PCT/KR2011/003989 KR2011003989W WO2011152652A3 WO 2011152652 A3 WO2011152652 A3 WO 2011152652A3 KR 2011003989 W KR2011003989 W KR 2011003989W WO 2011152652 A3 WO2011152652 A3 WO 2011152652A3
Authority
WO
WIPO (PCT)
Prior art keywords
aceclofenac
slow
day
clinical effect
release preparation
Prior art date
Application number
PCT/KR2011/003989
Other languages
English (en)
French (fr)
Other versions
WO2011152652A2 (ko
Inventor
이범진
정원태
최연웅
남규열
조상민
장재상
최민지
Original Assignee
한국유나이티드제약 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45067185&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2011152652(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 한국유나이티드제약 주식회사 filed Critical 한국유나이티드제약 주식회사
Priority to ES11790010.0T priority Critical patent/ES2561085T3/es
Priority to EP11790010.0A priority patent/EP2583674B1/en
Priority to RU2012150409/15A priority patent/RU2540471C2/ru
Priority to CN201180026974.1A priority patent/CN102917696B/zh
Priority to PL11790010T priority patent/PL2583674T3/pl
Publication of WO2011152652A2 publication Critical patent/WO2011152652A2/ko
Publication of WO2011152652A3 publication Critical patent/WO2011152652A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Abstract

본 발명은 아세클로페낙, 수용성 첨가제, 불용성 첨가제, 가용화제, 붕해제, 충진제를 포함하는 속방층과 아세클로페낙, 서방화기제, 붕해제, 결합제, 충진제, 유동화제, 가용화제, 활택제를 포함하는 서방층으로 구성된 이층정, 이중정 및 다층정을 특징으로 하는 최적의 약리학적 임상효과를 발현하는 1일 1회 경구투여 제어방출형 제제에 관한 것이다.
PCT/KR2011/003989 2010-06-01 2011-06-01 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제 WO2011152652A2 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES11790010.0T ES2561085T3 (es) 2010-06-01 2011-06-01 Preparación de liberación lenta de aceclofenaco que proporciona un efecto clínico farmacológico óptimo cuando se administra una vez al día
EP11790010.0A EP2583674B1 (en) 2010-06-01 2011-06-01 Aceclofenac slow-release preparation providing an optimum pharmacological clinical effect when administered once a day
RU2012150409/15A RU2540471C2 (ru) 2010-06-01 2011-06-01 Препарат ацеклофенака с медленным высвобождением, оказывающий быстрое болеутоляющее и противовоспалительное действие, обеспечивающий оптимальное фармакологическое и клиническое действие при приеме один раз в день
CN201180026974.1A CN102917696B (zh) 2010-06-01 2011-06-01 在每日施用一次时提供最佳药理学临床效应的醋氯芬酸缓释制剂
PL11790010T PL2583674T3 (pl) 2010-06-01 2011-06-01 Preparat aceklofenaku do powolnego uwalniania zapewniający optymalne kliniczne działanie farmakologiczne przy podawaniu raz na dobę

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100052030A KR101234254B1 (ko) 2010-06-01 2010-06-01 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제
KR10-2010-0052030 2010-06-01

Publications (2)

Publication Number Publication Date
WO2011152652A2 WO2011152652A2 (ko) 2011-12-08
WO2011152652A3 true WO2011152652A3 (ko) 2012-03-08

Family

ID=45067185

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/003989 WO2011152652A2 (ko) 2010-06-01 2011-06-01 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제

Country Status (8)

Country Link
EP (1) EP2583674B1 (ko)
KR (1) KR101234254B1 (ko)
CN (1) CN102917696B (ko)
ES (1) ES2561085T3 (ko)
HU (1) HUE026681T2 (ko)
PL (1) PL2583674T3 (ko)
RU (1) RU2540471C2 (ko)
WO (1) WO2011152652A2 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130106456A (ko) * 2011-04-29 2013-09-30 한국유나이티드제약 주식회사 약물 방출제어용 조성물
KR20130117128A (ko) * 2012-04-17 2013-10-25 한국유나이티드제약 주식회사 레보드로프로피진 함유 서방정 및 이의 제조방법
CN103830198B (zh) * 2012-11-28 2016-05-18 南京亿华药业有限公司 一种克霉唑阴道片及其制备方法
MX348595B (es) * 2013-08-02 2017-06-21 Laboratorio Raam De Sahuayo S A De C V Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
KR101506627B1 (ko) * 2013-12-26 2015-03-30 현대약품 주식회사 아세브로필린 및 친수성 서방기제를 포함하는 서방형 약학 조성물
CN104740692B (zh) * 2013-12-31 2017-09-05 上海微创骨科医疗科技有限公司 一种骨内固定植入物及其制备方法
WO2016042564A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of aceclofenac
KR102236650B1 (ko) 2019-04-16 2021-04-07 한국유나이티드제약 주식회사 아세클로페낙을 포함하는 약학조성물 및 이의 제조방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030003500A (ko) * 2001-07-03 2003-01-10 이범진 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
KR100806541B1 (ko) * 2005-05-11 2008-02-26 한국유나이티드제약 주식회사 아세클로페낙을 함유하는 제어 방출성 제제
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06316517A (ja) * 1993-02-22 1994-11-15 Grelan Pharmaceut Co Ltd 放出制御製剤
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
CN101342177B (zh) * 2007-07-12 2011-10-26 中国药科大学 氯诺昔康双层缓释片
CN100528144C (zh) * 2007-07-13 2009-08-19 浙江尖峰药业有限公司 醋氯芬酸缓释片及其制备方法
KR100836960B1 (ko) * 2007-09-07 2008-06-10 주식회사 서울제약 새로운 나이아신 제어방출형 제제
CN201179205Y (zh) * 2007-11-28 2009-01-14 北京星昊医药股份有限公司 双氯芬酸钠双释胶囊片
KR101076648B1 (ko) * 2008-12-04 2011-10-26 한국유나이티드제약 주식회사 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
KR101050076B1 (ko) * 2009-02-04 2011-07-19 한국유나이티드제약 주식회사 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
CN101658505A (zh) * 2009-09-29 2010-03-03 北京华禧联合科技发展有限公司 非布索坦的缓释制剂及其制备方法
KR101104138B1 (ko) * 2009-12-29 2012-01-13 전자부품연구원 배터리 사용가능 시간 산출장치 및 방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030003500A (ko) * 2001-07-03 2003-01-10 이범진 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
KR100806541B1 (ko) * 2005-05-11 2008-02-26 한국유나이티드제약 주식회사 아세클로페낙을 함유하는 제어 방출성 제제
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GHOSH, S. ET AL.: "Preparation and evaluation of aceclofenac sustained release formulation and comparison of formulated and marketed product", INT. J. MED. MEDICAL SCIENCES, vol. 1, no. 9, 2009, pages 375 - 382, XP055108024 *
See also references of EP2583674A4 *

Also Published As

Publication number Publication date
KR20110132170A (ko) 2011-12-07
CN102917696B (zh) 2015-04-01
CN102917696A (zh) 2013-02-06
ES2561085T3 (es) 2016-02-24
HUE026681T2 (en) 2016-07-28
EP2583674A2 (en) 2013-04-24
EP2583674A4 (en) 2014-06-25
RU2012150409A (ru) 2014-07-20
EP2583674B1 (en) 2015-11-18
PL2583674T3 (pl) 2016-05-31
KR101234254B1 (ko) 2013-02-18
RU2540471C2 (ru) 2015-02-10
WO2011152652A2 (ko) 2011-12-08

Similar Documents

Publication Publication Date Title
WO2011152652A3 (ko) 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제
NL301021I1 (nl) talazoparib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.
WO2009144550A3 (en) Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
EA201290982A1 (ru) Фармацевтические композиции, препятствующие злоупотреблению
WO2010115552A8 (en) Bispecific anti-erbb-3/anti-c-met antibodies
WO2011104652A3 (en) Veterinary compositions
WO2012022919A3 (fr) Formulations à base de nalbuphine et leurs utilisations
SMT201500266B (it) Compresse a doppio strato comprendenti elvitegravir, cobicistat, emtricitabina e tenofovir
WO2011051971A3 (en) Solid dispersion of rifaximin
IL212008A0 (en) Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules
WO2010066749A3 (en) Ulipristal acetate tablets
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
WO2011131943A8 (en) Pharmaceutical compositions
BR112012001353A2 (pt) anel vaginal, e, métodos para fabricar um anel vaginal e para dispensar um ou mais ingredientes farmaceuticamente ativos
EP2356674A4 (en) Dual metal interconnects for improved gap-fill, reliability, and reduced capacitance
MX355912B (es) Formulación de doxilamina y piridoxina y/o sus metabolitos o sales.
WO2011108826A3 (en) Complex formulation for oral administration comprising probiotic formulation and 5-ht4 receptor agonist and method for the preparation thereof
WO2011141488A3 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
EP4349369A3 (en) Increasing drug bioavailability in naltrexone therapy
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2011120903A3 (en) A fast dissolving pharmaceutical composition
WO2010115125A3 (en) Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
WO2007083190A3 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
EP2394644A3 (en) Trimetazidine Formulation With Different Release Profiles

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180026974.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11790010

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2011790010

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12012502386

Country of ref document: PH

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2012150409

Country of ref document: RU

Kind code of ref document: A